logo-loader
LSE:IXI OTC:PHYOF

IXICO PLC

Receive alerts
Market:
LSE
Price
13.35 GBX
Day Change
4.71%
Market Cap:
£29.23 m
52 weeks high
17.00
52 weeks low
6.26

In brief

IXICO is no ordinary Imaging Contract Research Organisation (iCRO). By unlocking valuable insights into drug safety and efficacy, IXICO has built a highly respected global reputation and a 20-year track record as an end-to-end iCRO. 

IXICO addresses the complex biomarker challenges associated with neurodegenerative conditions, expertly managing and analysing neuroimaging clinical trials in areas such as Alzheimer’s, Parkinson’s, Huntington's and other rare diseases.